Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 2
1997 1
1998 1
1999 2
2000 1
2001 2
2002 2
2003 2
2004 1
2005 2
2006 1
2007 1
2008 1
2012 1
2013 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

21 results
Results by year
Filters applied: . Clear all
Page 1
Rate of onset of inhibition of gut-wall and hepatic CYP3A by clarithromycin.
Quinney SK, Malireddy SR, Vuppalanchi R, Hamman MA, Chalasani N, Gorski JC, Hall SD. Quinney SK, et al. Among authors: hamman ma. Eur J Clin Pharmacol. 2013 Mar;69(3):439-48. doi: 10.1007/s00228-012-1339-x. Epub 2012 Jul 10. Eur J Clin Pharmacol. 2013. PMID: 22777148 Free PMC article. Clinical Trial.
Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7.
Williams JA, Ring BJ, Cantrell VE, Jones DR, Eckstein J, Ruterbories K, Hamman MA, Hall SD, Wrighton SA. Williams JA, et al. Among authors: hamman ma. Drug Metab Dispos. 2002 Aug;30(8):883-91. doi: 10.1124/dmd.30.8.883. Drug Metab Dispos. 2002. PMID: 12124305
21 results